PALB2 and breast carcinoma: Germline PALB2 variants are associated with a moderate-to-high risk of development breast cancer (Easton et al. 2015; Couch et al. 2017; Zhou et al. 2020; Breast Cancer Association Consortium et al. 2021), specifically in younger carriers (Antoniou et al. 2014).